Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis. (2021)

First Author: He S
Attributed to:  Technologies for the Treatment of Brain Diseases funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cellsig.2021.109931

PubMed Identifier: 33529758

Publication URI: http://europepmc.org/abstract/MED/33529758

Type: Journal Article/Review

Volume: 81

Parent Publication: Cellular signalling

ISSN: 0898-6568